Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine
Condition: Norovirus Infections Interventions: Biological: VXA-GI.1.NN; Biological: Placebo Tablet Sponsor: Vaxart Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2021 Category: Research Source Type: clinical trials